Robert Oberlender

916 citations

25 papers · 757 indexed · h-index 14

Impact in

Toxicology top 0.2%
- Forensic Toxicology and Drug Analysis
Cellular and Molecular Neuroscience top 5%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research

Papers in

Toxicology 5
- Forensic Toxicology and Drug Analysis 5
Cellular and Molecular Neuroscience 17
- Neurotransmitter Receptor Influence on Behavior 16
- Neuroscience and Neuropharmacology Research 5

Co-authors: David E. Nichols Andrew J. Hoffman Michael P. Johnson Peyton Jacob Alexander T. Shulgin Robert M. Riggs William K. Brewster D. E. NICHOLS
Journals: Journal of Medicinal Chemistry (9 papers)Pharmacology Biochemistry and Behavior (3 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Life Sciences (1 paper)Annals of the New York Academy of Sciences (1 paper)
Partner nations: United States Japan

In The Last Decade

Robert Oberlender

24 papers receiving 734 citations

Peers

Countries citing papers authored by Robert Oberlender

Since Specialization

Citations

This map shows the geographic impact of Robert Oberlender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Oberlender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Oberlender more than expected).

Fields of papers citing papers by Robert Oberlender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Oberlender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Oberlender. The network helps show where Robert Oberlender may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert Oberlender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Oberlender Line = papers co-authored together Robert Oberlender links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The characterization of the effect of locally applied N-methylquipazine, a 5-HT3 receptor agonist, on extracellular dopamine levels in the anterior medial prefrontal cortex in the rat: An in vivo microdialysis study Synapse ·Rocío Ribero Medina, Charles R. Ashby, Robert Oberlender, Yasuyuki Tanii, Masayoshi Kurachi, E.H. Rennie, Robert E. Strecker	1996	10
2	Effect of a Chiral 4-Alkyl Substituent in Hallucinogenic Amphetamines Journal of Medicinal Chemistry ·Robert Oberlender, K D Rudat, Michael P. Johnson, Xingqi Huang, D. E. NICHOLS	1995	7
3	Lysergamides Revisited PsycEXTRA Dataset ·利恵因, Xuelin Huang, Danuta Marona‐Lewicka, Robert Oberlender, Andi Arini Hidayanti	1994	7
4	Stereoselective LSD-like activity in d-lysergic acid amides of R- and S-2-aminobutane Journal of Medicinal Chemistry ·Robert Oberlender, 利恵因, Michael P. Johnson, Xuemei Huang, David E. Nichols	1992	16
5	2,3-Dihydrobenzofuran analogs of hallucinogenic phenethylamines Journal of Medicinal Chemistry ·David E. Nichols, Scott E. Snyder, Robert Oberlender, Michael P. Johnson, Xuemei Huang	1991	41
6	Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA) Journal of Medicinal Chemistry ·Michael P. Johnson, 李庭绵, Robert Oberlender, David E. Nichols	1991	48
7	5-iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine Pharmacology Biochemistry and Behavior ·D. E. NICHOLS, Michael P. Johnson, Robert Oberlender	1991	21
8	Structural variation and (+)-amphetamine-like discriminative stimulus properties Pharmacology Biochemistry and Behavior ·Robert Oberlender, David E. Nichols	1991	18
9	ChemInform Abstract: Synthesis and Pharmacological Examination of 1‐(3‐Methoxy‐4‐methylphenyl)‐2‐aminopropane and 5‐Methoxy‐6‐methyl‐2‐aminoindan: Similarities to 3,4‐(Methylenedioxy)methamphetamine (MDMA). ChemInform ·Michael P. Johnson, 李庭绵, Robert Oberlender, David E. Nichols	1991	1
10	Behavioral, biochemical and neurotoxicological actions of the α-ethyl homologue of p-chloroamphetamine European Journal of Pharmacology ·Michael P. Johnson, Huang Xuemei, Robert Oberlender, J. Frank Nash, David Nichols	1990	35
11	Nonneurotoxic tetralin and indan analogs of 3,4-(methylenedioxy)amphetamine (MDA) Journal of Medicinal Chemistry ·David E. Nichols, William K. Brewster, Michael P. Johnson, Robert Oberlender, Robert M. Riggs	1990	74
12	(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity. Journal of Pharmacology and Experimental Therapeutics ·Robert Oberlender, David E. Nichols	1990	45
13	Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA) analogues Pharmacology Biochemistry and Behavior ·David E. Nichols, Robert Oberlender, Kevin D. Burris, Andrew J. Hoffman, Michael P. Johnson	1989	10
14	Structure-Activity Relationships of MDMA-Like Substances PsycEXTRA Dataset ·David E. Nichols, Robert Oberlender	1989	39
15	Drug discrimination studies with MDMA and amphetamine Psychopharmacology ·Robert Oberlender, L.J. van den Herik	1988	121
16	ChemInform Abstract: Derivatives of 1‐(1,3‐Benzodioxol‐5‐yl)‐2‐butanamine: Representatives of a Novel Therapeutic Class. ChemInform ·David Nichols, Andrew J. Hoffman, Robert Oberlender, Peyton Jacob, Alexander T. Shulgin	1987	1
17	Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class Journal of Medicinal Chemistry ·David E. Nichols, Andrew J. Hoffman, Robert Oberlender, Peyton Jacob, Alexander T. Shulgin	1986	134
18	Synthesis and evaluation of 2,3-dihydrobenzofuran analogs of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats Journal of Medicinal Chemistry ·David E. Nichols, Andrew J. Hoffman, Robert Oberlender, Robert M. Riggs	1986	31
19	ChemInform Abstract: Synthesis und Evaluation of 2,3‐Dihydrobenzofuran Analogues of the Hallucinogen 1‐(2,5‐Dimethoxy‐4‐methylphenyl)‐2‐aminopropane: Drug Discrimination Studies in Rats. Chemischer Informationsdienst ·David E. Nichols, Andrew J. Hoffman, Robert Oberlender, Robert M. Riggs	1986	1
20	Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane Journal of Medicinal Chemistry ·Robert Oberlender, Paresh J. Kothari, David E. Nichols, Joseph E. Zabik	1984	15

About Robert Oberlender

Robert Oberlender is a scholar working on Toxicology, Cellular and Molecular Neuroscience, Clinical Psychology, Spectroscopy and Organic Chemistry, having authored 25 papers that have together received 757 indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (19 papers), Neurotransmitter Receptor Influence on Behavior (16 papers), Chemical synthesis and alkaloids (6 papers), Analytical Chemistry and Chromatography (5 papers), Neuroscience and Neuropharmacology Research (5 papers), Forensic Toxicology and Drug Analysis (5 papers), Cannabis and Cannabinoid Research (3 papers) and Plant-based Medicinal Research (2 papers). The work is most often cited by research in Toxicology (362 citations), Cellular and Molecular Neuroscience (533 citations), Clinical Psychology (442 citations), Pharmacology (145 citations) and Organic Chemistry (134 citations). Robert Oberlender has collaborated with scholars based in United States and Japan. Frequent co-authors include David E. Nichols, Andrew J. Hoffman, Michael P. Johnson, Peyton Jacob, Alexander T. Shulgin, Robert M. Riggs, Michael P. Johnson, David E. Nichols, William K. Brewster and D. E. NICHOLS. Their work appears in journals such as Journal of Medicinal Chemistry, Pharmacology Biochemistry and Behavior, Journal of Pharmacology and Experimental Therapeutics, Life Sciences and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact